Cardiovascular Business: Patients with type 2 diabetes and heart disease may require more aggressive, modern treatments

April 15, 2019

Treating coronary artery disease (CAD) in patients with type 2 diabetes (T2D) may require a more aggressive treatment approach than normal, according to a new scientific statement from the American Heart Association (AHA).

The document, published in full in Circulation, was written by Suzanne V. Arnold, MD, a cardiologist at Saint Luke’s Mid America Heart Institute in Kansas City, Missouri, and several colleagues. It was developed on behalf of the AHA’s Council on Lifestyle and Cardiometabolic Health and Council on Clinical Cardiology.

“What we’ve learned in the past decade is how you control glucose levels has a huge influence on cardiovascular risk,” Arnold said in a statement. “Lowering blood sugars to a certain level is not sufficient. There are now more options for controlling glucose in people with T2D, and each patient should be evaluated for their personal risk of cardiovascular disease, stroke and kidney disease. This combined health information, as well as the patient’s age, should be used to determine the appropriate therapies to lower glucose.”

Read the rest of the Cardiovascular Business article: Patients with type 2 diabetes and heart disease may require more aggressive, modern treatments

Related Content

Cardiology today
Cardiology Today: AHA: Aggressive treatment may benefit patients with diabetes, CAD
The treatment of CAD in patients with type 2 diabetes may need to be more aggressive compared with those without diabetes to reduce the risk for MI and other complications. Dr. Suzanne Arnold explains why in Cardiology Today.